• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

    3/26/25 9:00:00 AM ET
    $NSPR
    Medical/Dental Instruments
    Health Care
    Get the next $NSPR alert in real time by email

    MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 8:00AM Eastern Time / 5:00AM Pacific Time.

    A live audio webcast and replay of the presentation may be accessed for 90 days on the "News & Events" section of the company's website at: https://www.inspiremd.com/en/events/

    About InspireMD, Inc.

    InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

    Investor Contacts:

    Craig Shore

    Chief Financial Officer

    InspireMD, Inc.

    888-776-6804

    [email protected]

    Webb Campbell

    Gilmartin Group LLC

    [email protected]

    [email protected]



    Primary Logo

    Get the next $NSPR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NSPR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NSPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Tommasoli Andrea was granted 232,616 shares, increasing direct ownership by 47% to 727,694 units (SEC Form 4)

      4 - InspireMD, Inc. (0001433607) (Issuer)

      1/10/25 4:30:33 PM ET
      $NSPR
      Medical/Dental Instruments
      Health Care
    • Director Berman Michael was granted 32,491 shares, increasing direct ownership by 14% to 264,533 units (SEC Form 4)

      4 - InspireMD, Inc. (0001433607) (Issuer)

      1/10/25 4:30:18 PM ET
      $NSPR
      Medical/Dental Instruments
      Health Care
    • CEO and President Slosman Marvin was granted 558,417 units of Restricted Stock Units, increasing direct ownership by 30% to 2,410,536 units (SEC Form 4)

      4 - InspireMD, Inc. (0001433607) (Issuer)

      1/10/25 4:30:26 PM ET
      $NSPR
      Medical/Dental Instruments
      Health Care